Generics
Global Bioengineered Protein Drugs Market to Reach USD 521.3bn by 2027, According to Research and Markets
28 March 2023 - - The global bioengineered protein drugs market was estimated to have been worth USD 327.6bn in 2021, according to a report from Dublin-based Research and Markets.

Between...
Teva and Natco Launch Additional Strengths for the Generic Version of Revlimid in the US
17 March 2023 - - Israel-based Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) (TASE: TEVA) Teva Pharmaceuticals US affiliate and NATCO Pharma Ltd. (NSE: NATCOPHARM) (BSE: 524816) has launched ...
United States Specialty Generics Market to Reach USD 43.1bn by 2027, According to Research and Markets
14 March 2023 - - The "United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to Dublin-based...
Accord Healthcare adds Teriflunomide to oral medications range
14 March 2023 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Monday that it has added Teriflunomide to its range of oral medications.The product, which is formulated ...
Par Pharmaceutical commences shipping of first generic version of Allergan's Pylera
13 March 2023 - Par Pharmaceutical Inc, one of the operating companies of Endo International plc (OTC: ENDPQ), announced on Friday that it has started shipping the first generic version of Allergan�...
Glenmark Pharmaceuticals signs exclusive supply and distribution agreement with Cediprof
10 March 2023 - Glenmark Pharmaceuticals Inc., USA, (BSE:532296) (NSE:GLENMARK), a subsidiary of India-based Glenmark Pharmaceuticals, and Cediprof, Inc, a part of the Mexico-based Neolpharma Pharmace...